-
-
-
-
-
-
-
Repligen to acquire BioLife Solutions for ~$1.5B
-
-
-
-
-
-
-
Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
-
-
-
-
-
-
-
Repligen (RGEN) Misses Q2 EPS by 2c; offers guidance
-
-
-
-
-
-
-
Repligen (RGEN) Purchases Bioprocessing Analytics Portfolio from 908 Devices (MASS)
-
-
-
-
-
-
-
Repligen (RGEN) Tops Q3 EPS by 10c ; Offers Guidance
-
-
-
-
-
-
-
Repligen Announces Agreement to Acquire Chromatography Innovator Tantti
-
-
-
-
-
-
-
Repligen (RGEN) Reports In-Line Q4 EPS, provides guidance
-
1,231,059 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


